Drug Type XTEN fusion protein |
Synonyms cytotoxic T-lymphocyte protein 4 modulator (Amunix), CTLA-4-XTEN |
Target |
Action modulators |
Mechanism CTLA4 modulators(Cytotoxic T-Lymphocyte-Associated Antigen 4 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Graft Rejection | Discovery | United States | - | |
| Rheumatoid Arthritis | Discovery | United States | - |






